Justin Anderson, CEO of PreCheck Health Services, Inc. (Pink Sheets: HLTY), a distributor of medical screening devices for use by physicians in managing a patient’s health, called in to SmallCapVoice.com, Inc. to go over his efforts since taking the helm as CEO in December 2019, his company’s recent news with PreCheck as the distributor of Co-Diagnostics’ (Nasdaq: CODX) Logix Smart™ COVID-19 test in Panama, Ecuador and Russia, and what is next for his Company in the global response to coronavirus. In addition, Anderson touched on the other markets and revenue streams for HLTY with the acquisition of JAS Consulting, a provider of healthcare management, billing, and coding services, and PreCheck’s PC8B, an FDA-cleared and patented medical screening device. It can screen for multiple risk factors underlying certain chronic ailments, such as insulin resistance, cardiovascular disease (including PAD), endothelia dysfunction, digestive problems, and fatigue. The PC8B’s software helps the physician recommend a treatment plan for the patient.
This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $875 from the company on 3-17-20 for 30 days of Audio Interview service.